Blood Screening Market by Component, End-user and Geography - Forecast and Analysis 2023-2027

Published: Sep 2023

Pages: 152

SKU: IRTNTR76314

Snapshot

Blood Screening Market 2023-2027

The Blood Screening Market size is estimated to grow by USD 1,176.02 million at a CAGR of 7.42% between 2022 and 2027.

Blood screening is an essential process that ensures the safety of the blood supply by diagnosing potential infections or diseases in donated blood. Thus there is an increasing emphasis on comprehensive and efficient blood screening processes due to the increasing demand for blood transfusions. Additionally, the emergence of advancements in medical treatments surgeries, organ transplants, and trauma care has increased the demand for safe and compatible blood products fuelling the need for comprehensive blood screening. Furthermore, the increasing prevalence of chronic diseases and medical conditions may need surgeries or treatments with associated blood transfusions. Hence, such factors are positively impacting the market growth.

Technavio has segmented the market into component, end-user, and geography

The component segment is classified into reagents and kits, instruments, and software and services
The end-user segment is classified into blood banks and hospitals
The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the Size of the Blood Screening Market During the Forecast Period?

To learn more about this report, Request Free Sample

Blood Screening Market Segmentation by Component, End-user, and Geography Analysis

Component Analysis

Reagents and kits

The reagents and kits segment is estimated to witness significant growth during the forecast period. The reagents and kits segment is one of the crucial segments used in the laboratory testing process in order to screen donated blood for infectious diseases and ensure its safety for transfusion. Reagents can be referred to as substances or compounds utilized in laboratory tests to generate a chemical reaction with specific components in a sample, such as blood.

Get a glance at the market contribution of various segments View a PDF Sample

The reagents and kits segment was the largest segment and was valued at USD 1,540.85 million in 2017. There is an increasing adoption of reagents in blood screening to detect the presence of antibodies, antigens, or other markers associated with infectious diseases. This segment is a crucial part of the testing process and is selected depending on its specificity, sensitivity, and reliability in detecting specific pathogens. Blood screening plays a major role in ensuring that donated blood is free from infectious diseases, including HIV, hepatitis B and C, syphilis, and other pathogens. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

End-user Analysis

Blood bank

It is essential for blood banks to ensure that donated blood is safe from infectious diseases, including HIV, hepatitis B and C, and other pathogens. the main purpose of screening is that it helps to identify and discard potentially contaminated units. There is an increasing need for blood for different medical procedures, such as surgeries, trauma care, cancer treatments, and more. Therefore, it is important to have proper screening which minimizes the risk of complications from transfusions. There is an increasing demand for blood screening in order to prevent the spread of these diseases through transfusions due to outbreaks of infectious diseases or emerging health threats. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors that is significantly contributing to the growth of the global blood screening market in North America is due to the growing popularity of blood screening reflects the increasing recognition of its importance in ensuring the safety of the blood supply and preventing the transmission of infectious diseases. The blood screening process mainly comprises testing donated blood for different pathogens and health conditions before it is used for medical treatments. Factors such as advancements in medical technology, increased awareness of blood safety, regulatory requirements, and healthcare needs are fuelling the blood screening demand in North America. Hence, such factors are expected to drive the market growth in the region during the forecast period.

COVID Recovery Analysis

In 2020, during the COVID-19 pandemic, the growth of the global blood screening market witnessed a significant slowdown as there was a significant drop in blood donations and collections at blood banks and donation centers due to lockdowns, travel restrictions, and social distancing measures in North America. However, in 2021, the initiation of large-scale vaccination drives lifted the lockdown and travel restrictions, which led to the resumption of operations in blood donation centers. Such factors are expected to drive the market during the forecast period

Buy Now Full Report and Discover More

Key Blood Screening Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

BCAL Diagnostics Ltd: The company offers blood screening tests such as the BCAL test which is a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Blood Screening Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Significant Blood Screening Market Trends

A key factor shaping the blood screening market growth is the automation of the blood screening process. There is a significant transformation in the blood screening process due to the advent of automation such that it has enhanced efficiency, accuracy, and overall laboratory operations. Automated systems and robotics play a major role in different stages of the blood screening process, from sample processing to result analysis.

Moreover, the emergence of digital solutions for data management and integration is significantly contributing to enhancing the blood screening process. Some of these digital solutions include electronic health records, laboratory information systems, and data analytics for more efficient operations. Hence, such factors are positively impacting the market which in turn will drive the market growth during the forecast period.

Major Blood Screening Market Challenges

High costs associated with the blood screening process are one of the key challenges hindering the blood screening market growth. The process of blood screening is essential for ensuring the safety of blood transfusions, but the cost associated with acquiring, implementing, and maintaining advanced screening technologies can pose a significant threat to healthcare systems and blood banks. In addition, the cost of reagents, kits, and consumables used in blood screening adds to the overall cost, especially for high-throughput screening processes.

Moreover, the initial cost can include state-of-the-art screening technologies comprising expensive equipment, instruments, and robotic systems. Furthermore, additional resources are required to maintain quality control standards, especially for r validation, monitoring, and compliance with regulatory guidelines which adds to the total costs. Hence, such factors are negatively impacting the market which in turn will hinder the market growth during the forecast period.

Buy Now Full Report and Discover More

Key Blood Screening Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Blood Screening Market Customer Landscape

Segment Overview

The blood screening market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Component Outlook (USD Million, 2017 - 2027)
- Reagents and kits
- Instruments
- Software and services
End-user Outlook (USD Million, 2017 - 2027)
- Blood bank
- Hospitals
Geography Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World
  - Australia
  - Argentina
  - Brazil

Blood Screening Market Scope
Report Coverage	Details
Page number	152
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 7.42%
Market growth 2023-2027	USD 1,176.02 million
Market structure	Fragmented
YoY growth 2022-2023(%)	6.5
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 42%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Dr Lal PathLabs Ltd., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Harley Street Health Checks UK Ltd., Hemogenomics Pvt. Ltd., Laboratory Corp. of America Holdings, Mankind Pharma Ltd., Metropolis Healthcare Ltd., QuidelOrtho Corp., Siemens Healthineers AG, Syantra Inc., Thermo Fisher Scientific Inc., and Vijaya Diagnostic Centre Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Blood Screening Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of blood screening market between 2023 and 2027
Precise estimation of the blood screening market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of blood screening market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Component
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global blood screening market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global blood screening market 2017 - 2021 ($ million)

4.2 Component Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Component Segment 2017 - 2021 ($ million)

4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Component

6.1 Market segments
- Exhibit 30: Chart on Component - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Component - Market share 2022-2027 (%)

6.2 Comparison by Component
- Exhibit 32: Chart on Comparison by Component
- Exhibit 33: Data Table on Comparison by Component

6.3 Reagents and kits - Market size and forecast 2022-2027
- Exhibit 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)

6.4 Instruments - Market size and forecast 2022-2027
- Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)

6.5 Software and services - Market size and forecast 2022-2027
- Exhibit 42: Chart on Software and services - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Software and services - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Software and services - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Software and services - Year-over-year growth 2022-2027 (%)

6.6 Market opportunity by Component
- Exhibit 46: Market opportunity by Component ($ million)
- Exhibit 47: Data Table on Market opportunity by Component ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)

7.2 Comparison by End-user
- Exhibit 50: Chart on Comparison by End-user
- Exhibit 51: Data Table on Comparison by End-user

7.3 Blood bank - Market size and forecast 2022-2027
- Exhibit 52: Chart on Blood bank - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Blood bank - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Blood bank - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Blood bank - Year-over-year growth 2022-2027 (%)

7.4 Hospitals - Market size and forecast 2022-2027
- Exhibit 56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by End-user
- Exhibit 60: Market opportunity by End-user ($ million)
- Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 China - Market size and forecast 2022-2027
- Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)

9.9 Germany - Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.10 Canada - Market size and forecast 2022-2027
- Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.11 UK - Market size and forecast 2022-2027
- Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 BCAL Diagnostics Ltd.
- Exhibit 111: BCAL Diagnostics Ltd. - Overview
- Exhibit 112: BCAL Diagnostics Ltd. - Product / Service
- Exhibit 113: BCAL Diagnostics Ltd. - Key offerings

12.4 Becton Dickinson and Co.
- Exhibit 114: Becton Dickinson and Co. - Overview
- Exhibit 115: Becton Dickinson and Co. - Business segments
- Exhibit 116: Becton Dickinson and Co. - Key news
- Exhibit 117: Becton Dickinson and Co. - Key offerings
- Exhibit 118: Becton Dickinson and Co. - Segment focus

12.5 Bio Rad Laboratories Inc.
- Exhibit 119: Bio Rad Laboratories Inc. - Overview
- Exhibit 120: Bio Rad Laboratories Inc. - Business segments
- Exhibit 121: Bio Rad Laboratories Inc. - Key news
- Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 123: Bio Rad Laboratories Inc. - Segment focus

12.6 Dr Lal PathLabs Ltd.
- Exhibit 124: Dr Lal PathLabs Ltd. - Overview
- Exhibit 125: Dr Lal PathLabs Ltd. - Product / Service
- Exhibit 126: Dr Lal PathLabs Ltd. - Key offerings

12.7 Eurofins Scientific SE
- Exhibit 127: Eurofins Scientific SE - Overview
- Exhibit 128: Eurofins Scientific SE - Business segments
- Exhibit 129: Eurofins Scientific SE - Key news
- Exhibit 130: Eurofins Scientific SE - Key offerings
- Exhibit 131: Eurofins Scientific SE - Segment focus

12.8 F. Hoffmann La Roche Ltd.
- Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus

12.9 Grifols SA
- Exhibit 137: Grifols SA - Overview
- Exhibit 138: Grifols SA - Business segments
- Exhibit 139: Grifols SA - Key offerings
- Exhibit 140: Grifols SA - Segment focus

12.10 Harley Street Health Checks UK Ltd.
- Exhibit 141: Harley Street Health Checks UK Ltd. - Overview
- Exhibit 142: Harley Street Health Checks UK Ltd. - Product / Service
- Exhibit 143: Harley Street Health Checks UK Ltd. - Key offerings

12.11 Hemogenomics Pvt. Ltd.
- Exhibit 144: Hemogenomics Pvt. Ltd. - Overview
- Exhibit 145: Hemogenomics Pvt. Ltd. - Product / Service
- Exhibit 146: Hemogenomics Pvt. Ltd. - Key offerings

12.12 Laboratory Corp. of America Holdings
- Exhibit 147: Laboratory Corp. of America Holdings - Overview
- Exhibit 148: Laboratory Corp. of America Holdings - Business segments
- Exhibit 149: Laboratory Corp. of America Holdings - Key news
- Exhibit 150: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 151: Laboratory Corp. of America Holdings - Segment focus

12.13 QuidelOrtho Corp.
- Exhibit 152: QuidelOrtho Corp. - Overview
- Exhibit 153: QuidelOrtho Corp. - Product / Service
- Exhibit 154: QuidelOrtho Corp. - Key offerings

12.14 Siemens Healthineers AG
- Exhibit 155: Siemens Healthineers AG - Overview
- Exhibit 156: Siemens Healthineers AG - Business segments
- Exhibit 157: Siemens Healthineers AG - Key news
- Exhibit 158: Siemens Healthineers AG - Key offerings
- Exhibit 159: Siemens Healthineers AG - Segment focus

12.15 Syantra Inc.
- Exhibit 160: Syantra Inc. - Overview
- Exhibit 161: Syantra Inc. - Product / Service
- Exhibit 162: Syantra Inc. - Key offerings

12.16 Thermo Fisher Scientific Inc.
- Exhibit 163: Thermo Fisher Scientific Inc. - Overview
- Exhibit 164: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 165: Thermo Fisher Scientific Inc. - Key news
- Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus

12.17 Vijaya Diagnostic Centre Ltd.
- Exhibit 168: Vijaya Diagnostic Centre Ltd. - Overview
- Exhibit 169: Vijaya Diagnostic Centre Ltd. - Business segments
- Exhibit 170: Vijaya Diagnostic Centre Ltd. - Key offerings
- Exhibit 171: Vijaya Diagnostic Centre Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 172: Inclusions checklist
- Exhibit 173: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 174: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 175: Research methodology
- Exhibit 176: Validation techniques employed for market sizing
- Exhibit 177: Information sources

13.5 List of abbreviations
- Exhibit 178: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

blood screening market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis